Table 7 Estimates of ORSCL and ORMH (95% CI), and ORG (2.5–97.5pct): Australian data on SSRI-hip fracture (Study period = 180 days, Exposure Definition I)
Study period | 180 days | |||||
|---|---|---|---|---|---|---|
Days in 1 period | 1 day | 5 days | 20 days | 30 days | 60 days | 90 days |
M | 179 | 35 | 8 | 5 | 2 | 1 |
ORSCL | 2.02 (1.71–2.37) | 1.85 (1.58–2.17) | 1.76 (1.49–2.06) | 1.72 (1.46–2.02) | 1.59 (1.33–1.91) | 1.51 (1.24–1.83) |
ORMH | 1.67 (1.46–1.92) | 1.60 (1.39–1.84) | 1.59 (1.37–1.84) | 1.61 (1.38–1.88) | 1.55 (1.30–1.85) | 1.51 (1.24–1.83) |
ORG | 1.67 (1.49–1.90) | 1.60 (1.40–1.83) | 1.59 (1.39–1.83) | 1.61 (1.41–1.87) | 1.55 (1.30–1.81) | 1.51 (1.24–1.85) |